A Glance at the Development and Patent Literature of Tecovirimat: The First-in-Class Therapy for Emerging Monkeypox Outbreak

Small molecules as kinetoplastid specific proteasome inhibitors for leishmaniasis: a patent review from 1998 to 2021

(2022) Mohd Imran et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

Clinical features and management of human monkeypox: a retrospective observational study in the UK

(2022) Hugh Adler et al.   LANCET INFECTIOUS DISEASES

Nigella sativa L. and COVID-19: A Glance at The Anti-COVID-19 Chemical Constituents, Clinical Trials, Inventions, and Patent Literature

(2022) Mohd Imran et al.   MOLECULES

Development of Therapeutic and Prophylactic Zinc Compositions for Use against COVID-19: A Glimpse of the Trends, Inventions, and Patents

(2022) Mohd Imran et al.   Nutrients

The Therapeutic and Prophylactic Potential of Quercetin against COVID-19: An Outlook on the Clinical Studies, Inventive Compositions, and Patent Literature

(2022) Mohd Imran et al.   Antioxidants

Global human monkeypox outbreak: atypical presentation demanding urgent public health action

(2022) Akaninyene Otu et al.   Lancet Microbe

Synthetic molecules as DprE1 inhibitors: A patent review

(2021) Mohd. Imran et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

Mucormycosis medications: a patent review

(2021) Mohd. Imran et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

Innovations and Patent Trends in the Development of USFDA Approved Protein Kinase Inhibitors in the Last Two Decades

(2021) Mohd. Imran et al.   Pharmaceuticals

An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications

(2020) Andrew T. Russo et al.   Expert Review of Anti-Infective Therapy

Translation of Drug Interaction Knowledge to Actionable Labeling

(2019) Mongthuong T. Tran et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Oral Tecovirimat for the Treatment of Smallpox

(2018) Douglas W. Grosenbach et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tecovirimat: First Global Approval

(2018) Sheridan M. Hoy   DRUGS

A review of the monkeypox virus and a recent outbreak of skin rash disease in Nigeria

(2018) Auwal I. Kabuga et al.   JOURNAL OF MEDICAL VIROLOGY

Pharmacokinetic and Pharmacodynamic Modeling To Determine the Dose of ST-246 To Protect against Smallpox in Humans

(2012) Janet M. Leeds et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Safety and Pharmacokinetics of the Anti-Orthopoxvirus Compound ST-246 following a Single Daily Oral Dose for 14 Days in Human Volunteers

(2012) Jarasvech Chinsangaram et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetic Comparison of a Single Oral Dose of Polymorph Form I versus Form V Capsules of the Antiorthopoxvirus Compound ST-246 in Human Volunteers

(2012) Jarasvech Chinsangaram et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Development of the small-molecule antiviral ST-246®as a smallpox therapeutic

(2011) Douglas W Grosenbach et al.   Future Virology

Safety and Pharmacokinetics of the Antiorthopoxvirus Compound ST-246 following Repeat Oral Dosing in Healthy Adult Subjects

(2010) R. Jordan et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Development of ST-246® for Treatment of Poxvirus Infections

(2010) Robert Jordan et al.   Viruses-Basel

ST-246 Antiviral Efficacy in a Nonhuman Primate Monkeypox Model: Determination of the Minimal Effective Dose and Human Dose Justification

(2009) R. Jordan et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Single-Dose Safety and Pharmacokinetics of ST-246, a Novel Orthopoxvirus Egress Inhibitor

(2008) R. Jordan et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY